Chuanli Ren

Chuanli Ren

Auto-generated profile, based on publicly available information

Chuanli Ren


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 February 2018 in Cell Communication and Signaling
Verified
Journal Article
Open access
PDF file
DFDeyuan Fu
Deyuan Fu
JLJing Li
Jing Li
JWJinli Wei
Jinli Wei
ZZZhengquan Zhang
Zhengquan Zhang
YLYulin Luo
Yulin Luo
CRChuanli Ren
Chuanli Ren
High-mobility group box 2 (HMGB2) is implicated in tumorigenesis in various cancers. However, the clinical significance of HMGB2 signaling in human breast cancer progression remains unknown. We investigated HMGB2 expression in 185 cases of primary breast cancer and matched normal breast tissue specimens, and explored the underlying mechanisms of altered HMGB2 expression as well as the impact of this altered expression on breast cancer growth and on aerobic glycolysis using in vitro and animal models of breast cancer. HMGB2 was more highly expressed in tumor-cell nuclei of breast cancer cells than in the adjacent normal breast tissues (P < 0.05). Higher HMGB2 expression correlated with larger tumor size (P = 0.003) and advanced tumor stage (P = 0.033). A Cox proportional hazards model revealed that HMGB2 expression was an independent prognostic factor for breast cancer after radical resection (P < 0.05). Experimentally, knockdown of HMGB2 expression by stable transfected shRNA significantly decreased the growth and glycolysis of breast cancer cells both in vitro and in mouse models. Mechanically, promotion of breast cancer progression by HMGB2 directly and significantly correlated with activation of LDHB expression and inactivation of FBP1 expression. These results disclose a novel role for HMGB2 in reprogramming the metabolic process in breast cancer cells by targeting LDHB and FBP1 and provide potential prognostic predictors for breast cancer patients.

15 October 2011 in Cancer Biology & Therapy
Verified
Journal Article
Closed access
CRChuanli Ren
Chuanli Ren
CHChongxu Han
Chongxu Han
JZJinqing Zhang
Jinqing Zhang
PHPing He
Ping He
DWDaxin Wang
Daxin Wang
XZXiaohang Zhao
Xiaohang Zhao
The objective of the present study was to evaluate CA19-9 and CK8/18 expression patterns in pancreatic cancer cell lines induced by 5-fluorouracil (5-Fu), and in circulating tumor cells (CTCs) in peripheral blood of patients previously untreated with advanced pancreatic cancer. Furthermore, the goal was to test the relationship of dynamic of CTCs with the effects of the first cycle of chemotherapy. To accomplish this study, CD45 antibody coated beads were used to discard white blood cells in peripheral blood. This was done in combination with CA19-9-Alexa488 and CK8/18-Alexa594 immunofluorescence staining to identify CTCs in circulation from 41 advanced pancreatic cancer patients, before and after chemotherapy. The PL45 pancreatic cancer cell line was incubated with 20 µmmol/L 5-Fu for 12 and 24 hours to induce apoptosis, and the expression patterns of CA19-9 and CK8/18 were measured, and the extent of apoptosis was evaluated. Subsequently, apoptotic cells and CTCs were measured. Of 41 patients with stage...

25 March 2020 in The Analyst
Verified
Journal Article
Closed access
PDF file
JLJuan Li
Juan Li
HSHuifang Shen
Huifang Shen
SYSuhua Yu
Suhua Yu
GZGeshan Zhang
Geshan Zhang
CRChuanli Ren
Chuanli Ren
ZYZhanjun Yang
Zhanjun Yang
A novel manganese dioxide nanorod-anchored graphene oxide (MnO2NRs/GO) composite was synthesized by a simple hydrothermal method for the development of a highly sensitive electrochemical sensor for dopamine.

20 March 2015 in PLOS ONE
Verified
Journal Article
Open access
PDF file
HCHui Chen
Hui Chen
CRChuanli Ren
Chuanli Ren
CHChongxu Han
Chongxu Han
DWDaxin Wang
Daxin Wang
YCYong Chen
Yong Chen
DFDeyuan Fu
Deyuan Fu
MicroRNA (miR)-486-5p expression is often reduced in human cancers. However, its expression in gastric carcinoma and its relation to clinicopathological features and prognosis are unclear. Tissue microarrays were constructed from 84 patients with gastric adenocarcinoma (GC) who were undergoing radical resection. miR-486-5p expression was detected by miRNA-locked nucleic acid in situ hybridization, and its correlations with clinicopathological features and overall survival were analyzed. Bioinformatic studies predict that fibroblast growth factor 9 (FGF9) is a potential target gene of miR-486-5p. miR-486-5p was mainly located in the cytoplasm of GC cells and neighboring normal tissues. Compared with paracancerous normal tissue, miR-486-5p expression was decreased in 63.1% (53/84) of the GC samples, increased in 32.1% (27/84) and unchanged in 4.8% (4/84). FGF9 expression was decreased in 69.0% (58/84) of GC samples and increased in 31.0% (26/84) compared with normal paracancerous tissues using immunohistochemical analysis. Low or unchanged miR-486-5p expression (P = 0.002), tumor stage (P = 0.001), tumor status (P = 0.001), node status (P = 0.001), tumor size (P = 0.004), and depth of tumor invasion (P = 0.013) were significant negative prognostic predictors for overall survival in patients with GC. After stratification according to American Joint Committee on Cancer (AJCC) stage, low/unchanged miR-486-5p expression remained a significant predictor of poor survival in stage II (P = 0.024) and stage III (P = 0.003). Cox regression analysis identified the following predictors of poor prognosis: tumor status (hazard ratio [HR], 7.19; 95% confidence interval [CI], 1.75–29.6; P = 0.006), stage (HR, 2.62; 95%CI, 1.50–4.59; P = 0.001), lymph node metastasis (HR, 2.52; 95% CI, 1.27–4.99; P = 0.008), low/unchanged miR-486-5p (HR, 2.47; 95% CI, 1.35–4.52; P = 0.003), high level of FGF9 (HR, 2.41; 95% CI, 1.42–4.09; P = 0.001) and tumor size (HR, 2.50; 95% CI, 1.30–4.82; P = 0.006). Low or unchanged expression of miR-486-5p compared with neighboring normal tissues was associated with a poor prognosis, while high expression was associated with a good prognosis in GC. miR-486-5p may thus be useful for evaluating prognosis and may provide a novel target treatment in patients with GC.

16 May 2019 in New England Journal of Medicine
Verified
Journal Article
Closed access
CRChuanli Ren
Chuanli Ren
CHChongxu Han
Chongxu Han
To the Editor: Li and Izpisua Belmonte (Feb. 7 issue)1 systematically used organoids to establish various kinds of preclinical models of human diseases. However, they do not fully discuss possible modeling of the tumor immune microenvironment. We do not entirely agree with the authors that three-dimensional organoids are more limited than animal models because of their lack of vascularization and an immune system. Increasing numbers of studies have supported the use of three-dimensional organoid models for holistic study of the tumor immune microenvironment.2-5 Three-dimensional organoids represent the in vivo interaction of tumor and immune cells in the tumor microenvironment, and . . .

1 August 2023 in Journal of Analysis and Testing
Verified
Journal Article
Closed access
PDF file
YXYanping Xia
Yanping Xia
HCHui Chen
Hui Chen
RLRuixin Liu
Ruixin Liu
FSFeng Shi
Feng Shi
CRChuanli Ren
Chuanli Ren
ZYZhanjun Yang
Zhanjun Yang